New strategies to enhance photodynamic therapy for solid tumors Broekgaarden, M.
Introduction
Photodynamic therapy (PDT) entails the non-invasive photochemical destruction of solid tumors by local irradiation of a tumor-replete photosensitizer with visible light. Irradiation of the photosensitizer at a resonant wavelength results in the generation of highly thrombogenic and cytotoxic singlet oxygen ( 1 O 2 ) and/or reactive oxygen and nitrogen species (ROS and RNS, respectively) that induce vaso-occlusion, cell death, and an anti-tumor immune response [1] [2] [3] . PDT is relatively effective in the treatment of skin-, esophageal-, and head and neck cancers (complete response rates of 70-95%). However, several malignancies such as recurrent nasopharyngeal and urothelial carcinomas respond poorly to PDT (average complete response rate of approximately 50%) 1, [4] [5] [6] [7] . In non-resectable extrahepatic cholangiocarcinomas, a type of bile duct cancer that is associated with 0% survival 8 , PDT has been shown to prolong life expectancy from 3 to 16 months 9 , but to date has remained a palliative rather than a curative treatment option 8, 10 . Accordingly, PDT modalities need to be developed or improved to enable more effective treatment of these cancers.
A potential strategy to improve PDT efficacy in the abovementioned cancers is the use of liposomal zinc phthalocyanine (ZnPC). ZnPC is a second-generation photosensitizer with an absorption maximum at 674 nm. At this wavelength, light penetrates deeper into tissue than the light used to activate currently approved photosensitizers (630-655 nm), as a result of which a greater tumor volume can be irradiated more homogenously. ZnPC also has a high triplet state quantum yield and a substantially higher molar extinction coefficient (3×10 5 M-1•cm-1) than the clinically used photosensitizers (porfimer sodium: 1×10 3 M -1 •cm -1 , protoporphyrin IX: 5×10 3 M -1 •cm -1 , and meso-tetrahydrophenylchlorine: 3×10 4 M -1 •cm -1 ) 11 . Consequently, a lower light dose is required to activate the photosensitizer, which will translate to a more effective excitation of photosensitizer molecules throughout the entire tumor tissue.
Inasmuch as ZnPC is highly hydrophobic, a plasma-compatible carrier is required for the solubilization and systemic administration of ZnPC. Liposomes, or nanoscopic phospholipid vesicles capable of encapsulating hydrophobic and hydrophilic compounds at high concentrations, therefore constitute an ideal carrier system for ZnPC. Liposomes can concomitantly be used as a drug delivery system, whereby the encapsulated compound is passively or actively transported to solid tumors. In vascularized solid cancers, liposomes passively accumulate in the tumor interstitial spaces 12, 13 as a result of the enhanced permeability and retention (EPR) effect 14 . This biological feature ensures more photosensitizer accumulation in the tumor compared to native, healthy tissue 13, 15 . For example, the accumulation of hypocrellin A in the tumor tissue of mice bearing S-180 sarcoma xenografts is greater for the non-PEGylated liposomal formulation (0.48 μg/g tissue) than for the unencapsulated photosensitizer (0.31 μg/g tissue) 12 h post-injection 16 . Moreover, the ratios of hypocrellin A levels in tumor tissue versus peritumoral muscle and skin were 4.00 and 2.18 for the liposomal formulation, respectively, whereas these ratios were 2.58 and 1.24 for the unencapsulated photosensitizer, respectively, indicating greater tumor specificity of the liposomal photosensitizer 16 . It has also been shown that long-circulating liposomes are associated with greater tumor accumulating potential (6.92 ± 1.5% and 2.21 ± 0.4% of the injected dose was found in tumor tissue for long-circulating liposomes and conventional liposomes, respectively 12 ), reduced accumulation in non-cancerous tissue, and longer circulation times compared to conventional liposomes 12, 13 . Similarly, liposomal delivery of photosensitizer molecules to cancer cells occurs slower but yields higher intratumoral and intracellular photosensitizer concentrations than is the case with unencapsulated photosensitizers 16, 17 .
The aim of this study was therefore to develop, characterize, and optimize ZnPC-encapsulating interstitially targeted liposomes (ITLs) to be employed for EPR-mediated ZnPC delivery to PDT-recalcitrant solid tumors. Because of their degree of lethality, extrahepatic cholangiocarcinomas were used as a model system. The uptake of ITLs by cultured human extrahepatic cholangiocarcinoma (Sk-Cha1) cells was assessed by confocal microscopy, flow cytometry, and fluorescence spectroscopy. In vitro assays were performed to establish light dose-and ZnPC concentration-dependent ROS production kinetics and oxidative modification of model proteins and biomembranes. Lastly, the PDT efficacy of ITLs and the mode of PDT-induced cell death were assayed in Sk-Cha1 cells.
Materials and Methods

Chemicals and reagents
, and 1-palmitoyl-2-{12-[(7-nitro-2-1,3-benzoxadiazole-4-yl)amino]dodeca-noyl}-sn-glycero-3-phosphocholine (NBD-PC) were obtained from Avanti Polar Lipids (Alabaster, AL). 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol (DSPE-PEG, average PEG molecular mass of 2,000 amu), ZnPC (97% purity), HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), calcein, bovine serum albumin (BSA), and pyridine were acquired from Sigma-Aldrich (St. Louis, MO). Triton X-100 (TX-100) was purchased from Fluka (Buchs, Switzerland). Sodium chloride, α-tocopherol, and H 2 KPO 4 were from Merck KGaA (Darmstadt, Germany), dichlorodihydrofluorescein diacetate (DCFH 2 -DA), and Mitotracker Green DCF (MTG) were obtained from Molecular Probes (Eugene, OR). Sodium dodecyl sulfate (SDS) was from BioRad (Hercules, CA).
The lipids were dissolved in chloroform. The α-tocopherol was dissolved in chloroform at a 10-mM concentration, ZnPC was dissolved in pyridine at a 178-µM concentration, and DCFH 2 -DA was dissolved in DMSO at a 50-mM concentration. All dissolved lipids, DCFH 2 -DA, DCFH 2 , and α-tocopherol were briefly purged with N 2 gas. Lipids, α-tocopherol, and DCFH 2 -DA were stored in the dark at -20 °C. Concentrations refer to final concentrations unless noted otherwise.
Preparation of ITLs
Large unilamellar vesicles containing ZnPC were prepared by the lipid film hydration technique 18 . Lipids and ZnPC were mixed at the desired ratios. The organic solvent was desiccated under N 2 gas and the lipid film was vacuum exsiccated for at least 30 min to remove residual solvent molecules. The lipid film was hydrated with a buffer composed of 10 mM HEPES, 151 mM NaCl, pH = 7.4, 0.292 osmol/kg -1 (referred to as equilibration buffer from here onward) and homogenously dispersed by bath sonication for 10 min. The standard composition of ITLs was 66% DPPC, 30% cholesterol, and 4% DSPE-PEG. ZnPC was added from a stock solution at 178 μM ZnPC in pyridine at the indicated ZnPC:lipid ratios. ITL suspensions were always purged with N 2 gas where possible and stored at 4 °C in the dark.
Spectral properties of ZnPC and ZnPC-ITLs
The absorption spectra of ZnPC in pyridine (5 µM) and ZnPC-ITLs (ZnPC:lipid molar ratio of 0.001) in equilibration buffer were acquired with a Lambda 18 spectrophotometer (Perkin Elmer, Wellesley, MA). ZnPC and ZnPC-ITL fluorescence emission and excitation spectra were measured with a Cary Eclipse luminescence spectrometer (Varian, Palo Alto, CA) at 660 ± 5 nm and 680 ± 5 nm, respectively.
Characterization of ITLs
A rapid and simple assay was developed for the spectrophotometric quantification of ZnPC concentrations in ITL solutions. Aliquots of 100 µL of the ITL suspension (up to 5 mM final lipid concentration) were transferred to a glass tube and desiccated under a stream of N 2 gas. The pellet was dissolved in 1 mL pyridine, briefly sonicated, and centrifuged for 5 min at 1,000 × g to pellet lipid pre-cipitates. Absorption was measured at 674 nm and liposomal ZnPC concentrations were determined by solving the linear regression function of a standard curve (0-5.0 µM ZnPC in pyridine).
The total phospholipid concentration in the ITL suspension was determined by spectrophotometric analysis of derivatized inorganic phosphate as described by Rouser et al. 19 . The ZnPC:phospholipid ratio was calculated by dividing the spectrophotometrically derived ZnPC concentration by the measured phospholipid concentration. The measured phospholipid concentration accounted for 70% of the total lipid concentration since ITLs contained 30% cholesterol. Lipid concentrations mentioned from here onward refer to the total lipid concentration.
ITL size and polydispersity index (PDI) were determined by photon correlation spectroscopy (Zetasizer 3000, Malvern Instruments, Malvern, PA) from 10×10 measurements per sample using the following settings: unimodal analysis, refractive index (RI) dispersant = 1.331, viscosity = 0.8872, temperature = 20 °C, real RI = 1.46, core real RI = 1.327, radius ratio = 0.94117, Mark-Houwinck parameters: A = 0.50 and K = 0.000138, absorption = 0.3. The ζ-potential, which is a rough indication of the surface charge of the particle, was measured using electrophoretic light scattering (Zetasizer 3000, Malvern Instruments). The ζ-potential of ITLs was corrected for the ζ-potential of the equilibration buffer.
ROS detection assay
The in vitro generation of ROS during irradiation of ZnPC-ITLs was measured with the oxidation-sensitive fluorogenic probe 2' ,7'-dichlorodihydrofluorescein (DCFH 2 ). The oxidation of the non-fluorescent DCFH 2 to 2' ,7'-dichlorofluorescein (DCF) results in fluorescence. DCFH 2 was prepared from DCFH 2 -DA as described previously 20 and the final concentration of DCFH 2 in DMSO was approximately 7 mM. The ROS detection assay was performed as described in 20, 21 . A quartz cuvette containing a magnetic stirrer was placed in a temperature-controlled cuvette holder of a fluorescence spectrometer (Cary Eclipse). The spectrometer was operated in time-based acquisition mode with constant stirring, a set cuvette temperature of 20 °C, and λex = 500 ± 5 nm and λem = 525 ± 5 nm (i.e., absorption and fluorescence emission maxima of DCF, respectively). At t = -1 min, 1138 µL of equilibration buffer was added to the cuvette and at t = 0 min spectral acquisition was started. At t = 1 min, 2 µL of the DCFH 2 solution was added, at t = 2 min, 60 µL of the ZnPC-ITL suspension (0.5 mM final lipid concentration) was added, and at t = 3 min the sample was irradiated for 2 min at 500 mW (FieldMate power meter, Coherent, Santa Clara, CA) from above with a 1-mm internal diameter fiber-based, 671-nm continuous wave solid state diode laser (CNI Laser, Changchun, China).
The increase in DCF fluorescence at t = 5.98 min was used as a measure of ROS generation. Data (n = 9 per output power or ZnPC:lipid ratio) were corrected for background fluorescence (value at t = 2.98 min) and were normalized to the fluorescence emission intensity at t = 5.98 min of ITLs with the highest ZnPC:lipid ratio.
Protein oxidation assay
To determine whether the generated ROS induce protein oxidation, similar experiments were performed as described in section 2.5 using BSA as model protein and ROS as a substrate. BSA contains tryptophan (Trp) residues that autofluoresce at 344 nm when excited at 279 nm. Oxidation of Trp causes loss of fluorescence 22, 23 , which translates to a decrease in emission with increasing ROS generation and oxidative Trp modification during time-based fluorescence spectroscopy.
The procedure entailed: t = -1 min: addition of 1080 µL of 1 mg/mL BSA in equilibration buffer to the cuvette, t = 0 min: start spectral acquisition (λex = 279 ± 5 nm, λem = 344 ± 5 nm), t = 1 min: addition of 120 µL of the ZnPC-ITL suspension (0.5 mM final lipid concentration), and t = 2 min: laser irradiation for 2 min at either 500 mW or at different output powers as indicated in the results. Data (n = 9 per ZnPC:lipid ratio or output power) were normalized to the fluorescence emission intensity at t = 1.98 min. The percentage loss in emission intensity was calculated by dividing the average emission intensity at t = 4.98 min (BSA + ITLs during and after laser irradiation) by the average emission intensity at t = 1.98 min (BSA + ITLs before irradiation).
ZnPC-ITL-mediated membrane perturbation assays
To determine whether the generated ROS induce membrane oxidation and perturbation, similar experiments were performed as described in section 2.5 using cell phantoms (CPs, i.e., multilamellar vesicles as a model for cells) containing calcein at a concentration (53 mM) where its fluorescence is self-quenched. Upon ROS-induced membrane oxidation/perturbation, calcein leaks out of the CPs and becomes unquenched due to dilution, resulting in intense fluorescence 24 .
The CPs were composed of DPPC:DSPC:DPPS:DOPC:SDPC:cholesterol at a 39:10:20:5:5:20 molar ratio and a 1% molar fraction of α-tocopherol. CPs were prepared without or with ZnPC (0.003 ZnPC:lipid ratio) in the bilayer, as described in section 2.2. The lipid films were hydrated with an iso-osmolar calcein solution (53 mM calcein in MilliQ, 45 mM NaCl, pH = 7.4, 0.292 osmol•kg-1) to a 5-mM final lipid concentration. Immediately before experiments, unencapsulated calcein was removed by size exclusion chromatography (2 mL syringe, Sephadex G-50 fine (GE Healthcare, Chalfont St. Giles, UK)) in ice-cold equilibration buffer, gel volume of 2.2-2.5 mL, loading volume of 200 µL, 10 min centrifugation at 200 × g and 4 °C). The eluted CPs were kept on ice until use, typically within 1 h.
The spectrofluorometric experiments were performed at 20 °C. In the first test arm, the sequence of steps included: t = -1 min: addition of 1194 µL of equilibration buffer, t = 0 min: start spectral acquisition (λex = 488 ± 5 nm, λem = 522 ± 5 nm, i.e., the absorption and emission maxima of calcein), t = 1 min: addition of 6 µL of the ZnPC-CP solution (25 µM final lipid concentration), t = 3 min: laser irradiation for 2 min at 500 mW, and t = 6 min: addition of 12 µL of 10% TX-100 (to determine the fluorescence intensity at 100% calcein release). CPs lacking ZnPC were used as control.
In the second test arm, the ZnPC-lacking CPs were assayed in the presence of ZnPC-ITLs (section 2.2). The sequence of steps included: t = -1 min: addition of 1062 µL of equilibration buffer, t = 0 min: start spectral acquisition (λex = 488 ± 5 nm, λem = 522 ± 5 nm), t = 1 min: addition of 6 µL of ZnPC-lacking CP solution (25 µM final lipid concentration), t = 2 min: addition of 120 µL of the ZnPC-ITL suspension (0.5 mM final lipid concentration, ZnPC:lipid ratio of 0.003), t = 3 min: laser irradiation for 2 min at 250 mW, and t = 6 min: addition of 12 µL of 10% TX-100. ITLs devoid of ZnPC were used as control.
Cell culture
Human extrahepatic cholangiocarcinoma (Sk-Cha1) cells were a kind gift from Dr. Alexander Knuth (University Hospital Zurich) 25 . Sk-Cha1 cells were cultured at 37 °C, 5% CO2, 95% O2 in phenol red-containing RPMI 1640 (Gibco, Invitrogen, Carlsbad, CA). The culture medium was supplemented with 10% (v/v) fetal calf serum (Gibco), penicillin (100 U/mL, Lonza, Walkersville, MD), streptomycin (100 μg/mL, Lonza), amphotericin B (0.25 μg/mL, Lonza), 2 mM L-glutamine (Lonza), and 7×10-6 % (v/v) β-mercaptoethanol (Sigma-Aldrich). Cells were typically subcultured once a week to a 1:8 ratio using 1 mL Accutase (10 min under standard culture conditions, Innovative Cell Technologies, San Diego, CA) for detachment.
For seeding, the cells were harvested after Accutase treatment (10 min under standard culture conditions) and transferred to multi-wells plates (Costar, Corning Life Sciences, Tewksbury, MA) at a density of 7 × 10 5 cells/cm2 and 500 μL of medium/well. Cells typically grew into a confluent monolayer within 48 h.
PDT of cultured cells
All PDT experiments were performed on cell cultures grown in either 24-wells plates or 6-wells plates. The volume of medium was 500 μL/well in 24-wells plates and 1.5 mL/well in 6-wells plates. Cells were incubated with ZnPC-ITLs or ZnPC-lacking ITLs (control) for 30 min. To mimic the in vivo situation, the (ZnPC-)ITLs were not removed prior to PDT by washing but remained in the wells during PDT. PDT was performed with a 671-nm diode laser (CNI) at 500 mW for 60 s/well for cells in a 24-wells plate or at 500 mW for 285 s/well for cells in a 6-wells plate. The diameter of the circular spot conformed to the exact dimensions of the well (24-wells plate: 1.9 cm 2 , 6-wells plate: 9.5 cm 2 ) and the exposure time was adjusted such that all cells received a uniform cumulative radiant exposure of 15 J/cm 2 .
Dark toxicity and PDT efficacy assays
ITLs were prepared as described in section 2.2. ZnPC-lacking ITLs or ZnPC-ITLs with a ZnP-C:lipid ratio of 0.003 were used, confirmed spectrophotometrically as described in section 2.4. For dark toxicity experiments, cells were incubated in serum-free medium containing ZnPC-lacking ITLs or ZnPC-ITLs (both 500 µM final lipid concentration) for 8 h at standard culture conditions in the dark, after which cell viability assays (section 2.11) were performed. For PDT efficacy experiments, cells were incubated for 0.5 h in serum-free medium containing no ITLs (equilibration buffer only, control for high-power light exposure), ZnPC-lacking ITLs (PDT control, 500 µM final lipid concentration), or ZnPC-ITLs (500 µM final lipid concentration) and irradiated as described in section 2.9. Cell viability assays (section 2.11) were performed 8 h after irradiation. ZnPC dosage-dependent experiments were performed in the same manner as the PDT efficacy experiments, only the final lipid concentration of the ZnPC-ITLs was varied. Cell viability assays were performed 2-, 4-, or 8 h after irradiation.
Cell viability assay
Cell viability was determined by measuring mitochondrial activity with water-soluble tetrazolium-1 (WST-1, Roche Diagnostics, Basel, Switzerland). WST-1 is a chromogenic compound that is reduced by intact and active mitochondria to formazan, which can be measured by absorbance spectroscopy. After incubation at predefined durations the medium was replaced by 300 μL of fresh serum-and phenol red-free medium containing WST-1 at a 1:25 volume ratio. After 20-min incubation at standard culture conditions, absorption was read at 450 ± 30 nm (EL800 microplate reader, BioTek Instruments) using 600 nm as reference wavelength. The mean absorption was calculated for n = 3 separate experiments comprising n = 3 irradiated wells per experiment per time point or ZnPC-ITL concentration. Data were normalized to the mean absorption of control cells.
Analysis of the mode of cell death induction
To determine the mode of cell death induced by PDT with ZnPC-ITLs, cells were grown in 6-wells plates (section 2.8), incubated with 250 μM ZnPC-ITLs, and subjected to PDT as described in section 2.9. At 2-, 4-, or 8 h after PDT, the cell medium was removed and transferred to a 10-mL tube and kept on ice. Cells were washed once with 1 mL of PBS (37 °C), which was then transferred to the 10-mL tube. Next, 250 μL of Accutase was added to each well and the cell suspension was incubated for 10 min at standard culture conditions, after which the Accutase-treated cells were transferred to their respective 10-mL tubes. The tubes were centrifuged (5 min, 500 ×g, 4 °C), the cell pellets resuspended in 5 mL of ice cold PBS, and the tubes were centrifuged again (5 min, 500 ×g, 4 °C). The PBS was decanted and the cells were suspended in 100 μL of Annexin V binding buffer containing 5 μL of Alexa Fluor 488-conjugated Annexin V (AF488-AV) (Vybrant dead cell apoptosis kit, Molecular Probes, Life Technologies, Paisley, United Kingdom). After 15-min incubation, 400 μL of Annexin V binding buffer was added to the cells and the cell suspension was transferred to FACS tubes that were kept on ice. Five min prior to FACS (FACSCanto II, Becton Dickinson, Franklin Lakes, NJ), 1 μL of 100 μg/mL propidium iodide (PI, Molecular Probes) was added to stain necrotic cells. AF488-AV fluorescence was measured at λex = 488 and λem = 530 ± 30 nm and PI fluorescence was measured at λex = 488 nm and λem = 585 ± 42 nm. Ten thousand events were collected in the gated region. Data were analyzed for the percentage of unstained cells (healthy cells), Annexin V-positive cells (apoptotic cells), and Annexin V-and PI-positive cells (necrotic cells) (n = 3/group).
Lipid concentration-dependent ITL uptake
For the lipid concentration-dependent uptake assays, ITLs were prepared at a 5 mM final lipid concentration as described in section 2.2, only without ZnPC and with incorporation of 0.2 mol% rhodamine-PE at the expense of DPPC. Cationic liposomes (CLs), prepared in a similar manner but with 25 mol% of DC-chol at the expense of cholesterol, were used as positive control. ITLs and CLs were subjected to extrusion through 0.2-µm aluminum oxide membrane filters (Whatman), but not size exclusion chromatography.
For FACS assays, Sk-Cha1 cells were grown to ~90% confluence in 6-wells plates (section 2.8) and incubated with rhodamine-ITLs at 0-, 100-, 250-, or 500-μM lipid concentration or rhodamine-CLs at 0-, 50-, 100-, or 250-μM lipid concentration (section 2.4) for 2 or 4 h. After incubation, cells were washed thrice with PBS and harvested as described in section 2.8. Cells were suspended in 2 mL PBS, centrifuged (5 min, 500 × g, 4 °C), resuspended in 5 mL PBS, and centrifuged again. After decanting of the supernatant, cells were resuspended in 300 μL PBS and fixed by addition of 700 μL of ice-cold 96% ethanol during gentle swerving for 1 min on a plate shaker. Next, 9 mL of PBS was added and the cells were centrifuged for 5 min at 500 × g at 4 °C and resuspended in 1 mL of PBS for FACS (LSR Fortessa, Becton Dickinson). Rhodamine fluorescence was measured at λex = 561 nm and λem = 610 ± 20 nm. Ten thousand events were collected in the gated region.
Additionally, Sk-Cha1 cells were grown (section 2.8) to 100% confluence in 24-wells plates. The medium was aspirated and replaced with serum-free medium (37 °C, 1 mL/well) containing rhodamine-ITLs at 0-, 100-, 250-, or 500-μM final lipid concentration or rhodamine-CLs at 0-, 50-, 100-, or 250-μM final lipid concentration (section 2.4). The cells were incubated with ITLs or CLs for 2-or 4 h at standard culture conditions. Following incubation, cells were washed thrice with 0.5 mL of PBS and fluorescence was measured at λex = 560 ± 20 nm and λem = 620 ± 20 nm with a fluorescence plate reader (Synergy HT, BioTek Instruments). Cells that had been incubated with medium only were used as control. Due to the adhesion of PEGylated ITLs to the material of the culture plate in the absence of cells (not shown), it is imperative that this assay is performed after cells have become fully confluent.
For confocal microscopy, Sk-Cha1 cells were grown to ~90% confluence in 6-wells plates on collagen I-coated circular microscope slides and incubated for 4 h with rhodamine-ITLs or rhodamine-CLs (250 µM final lipid concentration). After incubation, cells were washed thrice with 0.5 mL of PBS, resuspended in 0.5 mL of PBS, and stained with 2.5 µL of 200 nM MTG (from a 1-μM stock in DMSO) for 0.5 h at standard culture conditions. Subsequently, cells were mounted on rectangular microscope slides using DAPI-containing Vectashield mounting fluid (Vector Laboratories, Burlingame, CA). Imaging was performed using a Leica TCS-SP2 confocal laser scanning microscope (Leica Microsystems, Wetzlar, Germany). Cells were analyzed for fluorescence of DAPI (λex = 361 nm, λem = 405 ± 40 nm), MTG (λex = 488 nm, λex = 520 ± 30 nm), and rhodamine (λex = 561 nm, λem = 575 ± 40 nm).
Particle size-dependent ITL uptake
ITLs were prepared at a 5-mM lipid concentration as described in section 2.2 without ZnPC but with 5 mol% NBD-PC at the expense of DPPC. To ensure maximum particle size homogeneity, ITLs were extruded 21× through 0.8-µm, 0.4-µm, 0.2-µm, or 0.1-µm polycarbonate membrane filters (Whatman) at 70 °C using a mini-extruder (Avanti Polar Lipids). To ensure easy extrusion and maximize population homogeneity, ITLs extruded through the smaller pore size filters were first extruded 11× through larger pore size filters. ITLs were characterized for size, PDI, and phospholipid content as described in section 2.4.
Sk-Cha1 cells were cultured in supplemented RPMI 1640 (section 2.8) to 100% confluence in 24-wells plates. The cell culture medium was aspirated and replaced with serum-and phenol redfree medium (37 °C) containing 0, 10-, 20-, 40-, 80-, or 160 μL of NBD-ITLs (final volume of 300 µL/ well, n = 3 per ITL size and volume). The cells were incubated with the ITLs for 30 min at standard culture conditions. Following incubation, cells were washed twice with 1 mL of PBS (37 °C) and fluorescence was measured at λex = 460 ± 40 nm and λem = 520 ± 20 nm in a PBS volume of 1 mL/well with a fluorescence plate reader (Synergy HT, BioTek Instruments).
After fluorescence measurements, the PBS was decanted and 200 µL of cell lysis buffer (0.1% (w/v) SDS and 20% (v/v) methanol in MilliQ) was added to each well. The plates were incubated at room temperature for at least 1 h during gentle rocking. Next, protein content was determined using a bicinchoninic acid protein assay kit (Thermo Scientific, Waltham, MA) with bovine serum albumin as reference. The fluorescence intensity was normalized to protein content and expressed as fluorescence intensity per μg protein per particle diameter and final phospholipid concentration.
Statistical analysis
Statistical analysis was performed in GraphPad Prism (GraphPad Software, La Jolla, CA) using ANOVA with a Bonferroni post-hoc test. Normal distribution of the data sets was confirmed by a D'Agostino Pearson omnibus test. A p-value of ≤ 0.05, designated with (*), was considered statistically significant. A p-value of ≤ 0.01 were designated as (**) and a p-value of ≤ 0.001 was designated as (***). Bland-Altman analysis 26 was also performed in GraphPad Prism. The mean and standard deviations are shown in all figures unless indicated otherwise.
Results
Determination of liposomal ZnPC concentration
Liposomal ZnPC concentrations were assayed by absorbance spectroscopy. The red absorption maximum of ZnPC in pyridine lies at 674 nm (Fig. 1A) , and the 674-nm absorbance is linear in a ZnPC concentration range of 0-5 µM (Fig. 1B) . A linear fit equation of the ZnPC standard curve (in pyridine) yielded a molar extinction coefficient of 2.74 × 10 5 M -1 •cm -1 , which was used to determine the ZnPC concentration in liposomal suspensions after desiccating under N 2 gas and redissolving in pyridine. To rule out an interfering effect of phospholipids on the spectroscopic quantification of ZnPC, the absorbance at 674 nm was measured of 0.5 µM ZnPC in pyridine containing increasing DPPC concentrations, i.e., the major phospholipid constituent of ZnPC-ITLs. Fig. 1C demonstrates that the spectrophotometric quantification of ZnPC was not affected by the presence of DPPC up to a final phospholipid concentration of 2.5 mM in pyridine. At higher phospholipid concentrations the absorbance values fluctuated due to lipid precipitation, which was resolved by centrifugation prior to absorbance spectroscopy.
In preliminary experiments it became evident that liposomal ZnPC concentrations were affected by the liposome preparation procedure that included freeze-thawing, extrusion, and size exclusion chromatography. This was due to the formation of ZnPC aggregates during freeze-thawing (at ZnPC:lipid ratios of >0.004), adsorption of ZnPC to the aluminum oxide filter material during extrusion, and/or retention of ZnPC in the Sephadex matrix during size exclusion chromatography, resulting in a reduced encapsulation efficiency and a discrepancy between the initial and the final ZnPC:lipid ratio (not shown). Therefore, ITLs were prepared without freeze-thawing, extrusion, and size exclusion chromatography. To homogenously disperse ZnPC and lipids, the hydrated lipid films were sonicated for ~10 min, yielding ITLs of 126.5 ± 16.6 nm at a PDI of 0.189 ± 0.083 (n = 11) and a ζ-potential of 9.7 ± 0.8 mV (n = 3). Fig. 1D presents a Bland-Altman plot confirming that, in the 0-20 µmol ZnPC range, this preparation protocol yielded amounts of liposome-associated ZnPC that were comparable to the amounts of ZnPC initially added to the lipid mixture (mean ± SD retention of 98.3 ± 5.8%). This preparation protocol was therefore standardly employed for the preparation of (ZnPC-)ITLs unless noted otherwise.
Optimization of ZnPC:lipid ratios for PDT
The ITLs should be prepared such that they produce a maximum amount of ROS upon irradiation. For optimal ROS yields, it is imperative that ZnPC is encapsulated in monomeric state in the lipid bilayer 27 , inasmuch as dimer-or multimerization typically affect triplet state quantum yields and hence the ROS-generating capacity. The state of liposomal ZnPC was investigated by means of fluorescence spectroscopy and subsequently confirmed with substrate oxidation assays (section 3.3). First, the effect of liposomal encapsulation on ZnPC fluorescence emission and excitation spectra was determined. As shown in Fig. 1E , there were no notable spectral shifts in the emission and excitation maxima of liposomal ZnPC compared to ZnPC in pyridine, attesting that phospholipids do not alter the electronic transition states of ZnPC. The excitation spectrum completely overlapped with the ground state absorption spectrum ( Fig. 1A and 1E ), which indicates that a single species is responsible for the fluorescence (i.e., no tautomerization/isomerization occurs in the excited state) and that the fluorescence does not emanate from an impurity. A Stokes shift of 4 nm (not shown) further confirms the absence of notable intermolecular charge transfer processes in the excited state. However, the very high detector voltage required to measure fluorescence (relative to equimolar concentrations of e.g., calcein, not shown) reflects a low fluorescence quantum yield of ZnPC, which is in agreement with intersystem crossing to the triplet state.
Next, ZnPC fluorescence intensities were measured as a function of the ZnPC:lipid ratio in ITLs (mean ± SD diameter of 127 ± 17 nm and PDI of 0.184 ± 0.083). As shown in Fig. 1F , the fluorescence intensity-ZnPC:lipid ratio relationship is linear up to a ZnPC:lipid ratio of 0.003, after which the fluorescence intensities taper off and plateau. This indicates that at ZnPC:lipid ratios of >0.003 the ZnPC may no longer be monomeric. Therefore, ITLs with a ZnPC:lipid ratio of 0.003 were used in the subsequent experiments unless indicated otherwise.
ROS-generating potential of ITLs
To determine the ROS-generating potential of ITLs, ROS production by ITLs with increasing ZnPC content was measured in real time by fluorescence spectroscopy using the oxidation-sensitive fluorogenic probe DCFH 2 . ZnPC-ITLs exhibited a strong ROS-generating capacity upon irradiation with 671-nm laser light at 500 mW ( Fig. 2A, red trace) , as evidenced by the instantaneous increase in DCF fluorescence. Irradiation of ITLs not containing ZnPC at the same power did not produce any ROS ( Fig. 2A, black trace) . DCF fluorescence reached a plateau well within 1 min of irradiation, suggesting that either the ZnPC had ceased to generate ROS or that all DCFH 2 had been oxidized. Given that the ZnPC-ITLs turned from blue before irradiation to white after irradiation, the plateau phase was most likely attributable to complete oxidative modification of ZnPC, which is a blue chromophore. The experiments further revealed that the extent of DCFH 2 oxidation was highly dependent on the ZnPC:lipid ratio of ITLs. When the DCF fluorescence intensity was plotted as a function of Zn-PC:lipid ratio (Fig. 2B) , an increase in the extent of DCFH 2 oxidation prevailed up to a ZnPC:lipid ratio of 0.003, after which the DCF fluorescence intensities abated and plateaued. This pattern is quite similar to the pattern observed for ZnPC fluorescence (Fig. 1F) .
To determine a possible relationship between laser power and the maximum oxidation potential of ZnPC-ITLs, ITLs were prepared at a ZnPC:lipid ratio of 0.003 and exposed to increasing laser powers for 2 min. The results (Fig. 2C) show that the maximum DCFH 2 oxidation was achieved at a power of 501 mW. Higher laser powers (only 718 mW is shown) did not result in a greater extent of ROS production but induced faster reaction kinetics, as evidenced by the steeper slope of the traces with increasing power. As a result, laser powers lower than 501 mW did not result in a complete oxidation reaction of DCFH 2 during the 2-min irradiation interval.
Protein oxidation potential of ITLs
In order for ITLs to confer cytotoxicity, the ROS that are produced during irradiation must be able to chemically modify biomolecules. In order to investigate protein oxidation, the fluorescence emission of Trp in any model protein can be monitored since Trp is an autofluorescent amino acid that loses its intrinsic fluorescence upon oxidative cleavage of the five-membered indole ring 22, 23 . BSA was previously used as a model protein in a study that investigated the oxidizing potential of hematoporphyrin derivative and tetramethylenepyridinium porphyrin 23 . BSA was therefore also employed as model protein in this study. A similar experimental setup as in section 3.3 was used to test whether the ROS generated by ZnPC-ITLs are capable of oxidizing Trp residues in BSA.
Irradiation of ZnPC-ITLs at 500 mW induced an instantaneous decline in Trp fluorescence (Fig. 2D, red trace) , whereas this effect was absent in ITLs that did not contain ZnPC (Fig. 2D , black trace). Similar to the oxidation of DCFH 2 ( Fig. 2A) , maximum BSA oxidation was achieved well within 1 min of irradiation, after which Trp fluorescence remained at a constant level despite of continued irradiation. The extent of BSA oxidation (determined at t = 4.98 min and corrected for background at t = 1.98 min) increased with increasing ZnPC:lipid ratio up to a ZnPC:lipid ratio of 0.003 ( Fig. 2E ). Beyond this ratio there were no differences in the degree to which Trp was oxidized.
Experiments performed with ZnPC-ITLs (ZnPC:lipid ratio of 0.003) and increasing laser power demonstrated that the extent as well as the rate of BSA oxidation were power-dependent (Fig.  2F) . The extent of BSA oxidation, determined by the difference between Trp fluorescence before and after laser irradiation, was in the order of 25 mW < 51 mW < 103 mW < 220 mW = all output powers up to 1,200 mW, achieving a maximum oxidation of approximately 60% of the total Trp residues. Also, the higher the irradiance the faster the rate of Trp oxidation, as evidenced by the increasing steepness of the fluorescence traces during the first minute of irradiation (Fig. 2F) . These results are qualitatively comparable to the observations made in the DCFH 2 power-dependent oxidation assays (Fig. 2C) .
Membrane-perturbing potential of ITLs
Permeabilization of the cell membrane is a precursor event to necrosis, which is the preferred mode of PDT-induced cell death because the corollary leakage of cytosolic constituents pro-motes an anti-tumor immune response that in turn enhances the removal of the malignancy 28 . It is well-established that 1 O 2 , the main ROS produced by ZnPC 29 is capable of oxidizing lipids 30 that may result in compromised membrane integrity as a result of lipid packing defects.
In the following set of experiments, the membrane disrupting capacity of irradiated ZnPC was investigated in two possible scenarios. The first scenario assumes that the ZnPC-ITLs are endocytosed by cancer cells and that consequently the ZnPC is incorporated into the cell membranes. The second scenario assumes that the ZnPC-ITLs are not taken up by cancer cells and that ZnPC-ITLs are the origin of ROS production. In these experiments, CPs were prepared as cancer cell mimetic containing a self-quenching concentration of calcein to act as a reporter probe for membrane permeabilization. With respect to the first scenario, irradiation of CPs that contained ZnPC in the membrane resulted in instantaneous calcein leakage, as evidenced by the steep rise in calcein fluorescence (Fig.  3A, black trace) . Calcein leakage continued even after the laser had been turned off. No calcein leakage was observed for CPs that did not contain ZnPC (Fig. 3A, red trace) , indicating that 671-nm laser irradiation was not responsible for the membrane perturbation. The finding that ZnPC-containing CPs exhibited calcein leakage during laser irradiation suggests that the calcein leakage from CPs most likely resulted from oxidation of mono-and polyunsaturated fatty acids (DOPC and SDPC, respectively), cholesterol, and/or α-tocopherol and consequent cell phantom leakage due to disrupted membrane integrity. However, when CPs were co-incubated with ZnPC-ITLs, no calcein release from CPs was observed ( Figure 3B, black trace) , implying that a distally located ROS source is ineffective in inflicting membrane permeabilization by oxidative modification of membrane constituents.
In vitro PDT efficacy of ZnPC-ITLs
Despite the absence of ZnPC-ITL-mediated membrane perturbation in CPs (Fig. 3B ), the PDT Addition of ITLs or ZnPC-ITLs at a 500-µM lipid concentration without laser irradiation had no effect on cell viability (Fig. 4A, left panel) , indicating that neither the ZnPC nor the ITLs were toxic to Sk-Cha1 cells. Similarly, laser irradiation of cells incubated in PBS or in PBS containing control ITLs did not affect cell viability, whereas laser irradiation of cells incubated with ZnPC-ITLs at a 500-µM lipid concentration was highly lethal (Fig. 4B, right panel) . Eight hours after irradiation, cell viability in the latter group was reduced to 19.6 ± 6.6%.
As shown in Fig. 4C , post-PDT cell viability was dependent on the quantity of ITLs in an inversely proportional manner up to a final lipid concentration of 500 μM, with 100 μM as the minimal lipid concentration at which significant cell death was induced by PDT. At higher lipid concentrations (250 and 500 μM) there were distinctive cell death patterns between 2/4 h post-PDT versus 8 h post-PDT, as evidenced by the 40-50% lower cell viability in the latter time interval compared to the 2-and 4-h time interval. This pattern suggests that either additional cell death pathways are triggered or that the cell death signaling is amplified between 4 and 8 h after PDT.
Mode of cell death induced by PDT with ZnPC-ITLs
To identify the mode of cell death induced by PDT with ZnPC-ITLs, cells were incubated with ZnPC-ITLs (ZnPC:lipid ratio 0.003, 250 µM final lipid concentration) and subjected to PDT. Subsequently, cells were stained for apoptosis (AF488-AV) and necrosis (PI) 2-, 4-, and 8 h after PDT and analyzed by FACS. PDT induced extensive apoptotic and necrotic cell death after 2-and 4 h, whereby necrosis predominated over apoptosis ( Fig. 5 ). At 8 h post-PDT, the relative amount of non-affected cells doubled versus the 4 h time interval, whereby the population necrotic cells declined by approximately a third and the number of apoptotic cells almost doubled. It therefore appears that cell repair and/or survival pathways are activated following PDT that are not necessarily linked to mitochondrial uncoupling/damage, given the fact that this trend was not observed in the cell viability assays performed with the mitochondrial reagent WST-1 (Fig. 4C ).
In vitro ITL uptake by Sk-Cha1 cells
ITLs were designed as 'stealth liposomes' with the inclusion of PEGylated lipids 31 , and were therefore not expected to be taken up by cells. Since PDT of Sk-Cha1 cells in the presence of Zn-PC-ITLs resulted in cell death (Figs. 4 and 5) yet PDT of ZnPC-ITLs did not cause membrane permeabilization in CPs (Fig. 3B) , the uptake of ITLs by Sk-Cha1 cells was investigated as a possible cause of for the PDT-mediated cytotoxicity.
Flow cytometric analysis ( Fig. 6A-C) , fluorescence spectroscopy (Fig. 6D) , and confocal microscopy ( Fig. 6E ) revealed that ITLs, which have a ξ-potential of -2.43 ± 1.33 mV, were taken up to a moderate degree by Sk-Cha1 cells in an incubation time ( Fig. 6C ) and lipid concentration-dependent manner (Fig. 6D ). The uptake of positively charged CLs (ξ-potential of 3.0 ± 3.0 mV) was approximately two-fold greater than that of ITLs ( Fig. 6A-D) at equimolar lipid concentrations. The fluorescence of MTG and rhodamine-PE partially overlapped (Fig. 6E) , indicating that ITL constituents at least partially colocalized with the mitochondrial membrane (although not exclusively).
The last set of experiments investigated the relationship between ITL diameter and cellular uptake. Inasmuch as every liposomal formulation has a heterogeneous distribution of particle sizes, it is possible that only a size-confined subpopulation of ITLs is preferentially taken up by cancer cells. To test this, ITLs of different diameters and high size homogeneity were prepared and assayed for uptake by Sk-Cha1 cells. The resulting ITL diameters, PDIs, and size distributions are provided in Fig.  7 per extrusion filter used.
Uptake of ITLs by Sk-Cha1 cells was observed at all particle diameters. The uptake of ITLs was indiscriminate at particle sizes of 417-and 275 nm, regardless of the quantity of ITLs present in the incubation medium. At a mean ITL diameter of 183 nm the fluorescence intensity was higher at all lipid concentrations compared to the larger particle diameters, indicating an increased level of uptake. The uptake was highest for the smallest-diameter ITLs (117 nm) across the entire lipid concentration range. Despite the preferential uptake of smaller-diameter ITLs, it can be concluded that the PDT-induced cell death described in sections 3.6 and 3.7 was not attributable to the exclusive uptake of a subpopulation of ZnPC-ITLs.
Discussion
In this study a liposomal delivery system was developed and optimized for ZnPC, a second generation photosensitizer with more favorable optical and photochemical properties than most of the currently approved photosensitizers 32, 33 . The ITLs not only serve as a means to render a highly lipophilic photosensitizer compatible with plasma (i.e., required for systemic administration), but also to enable accumulation of the photosensitizer in the tumor stroma at high concentrations -a process that is facilitated by the EPR effect 12, 34, 35 . In order to allow sufficient accumulation of ITLs in the tumor interstitial spaces, the ITLs were PEGylated so as to increase circulation half life 34, 36, 37 and thereby the likelihood that the ZnPC-ITLs diffuse through the fenestrations in intratumoral vascu- lature. Although the ITLs must be further validated in vivo, the in vitro data presented here provide compelling proof-of-concept for the utility of ZnPC-ITLs in PDT of solid cancers.
The in vitro proof-of-concept is derived from the most important findings of this study, i.e. that (1) ITLs composed of DPPC:cholesterol:DSPE-PEG at a 66:30:4 molar ratio and a 0.003 ZnPC:lipid ratio effectively produce ROS that in turn is capable of oxidizing proteins and perturbing biomembranes; (2) ZnPC-ITLs do not exhibit any dark toxicity in cancer cells during 8-h incubation; (3) the ZnPC-ITLs induce considerable cell death upon irradiation in a cancer cell line that has been derived from a PDT-recalcitrant type of cancer (extrahepatic cholangiocarcinoma); (4) PDT with ZnPC-ITLs induces both apoptosis and necrosis as a result of ZnPC-ITL uptake, with necrosis being the more prominent mode of cell death; and (5) PDT efficacy is positively correlated to the quantity of ITLs taken up, which in turn is governed by ITL ξ-potential (uptake is improved with cationic surface charge) and size (uptake is improved at smaller particle diameters).
One of the most imperative steps in developing a liposomal formulation for lipophilic photosensitizers is to optimize the photochemical properties of the photosensitizer in the context of a phospholipid bilayer. Phthalocyanines exhibit a strong tendency to dimerize, which impairs energy transfer to molecular oxygen 38 and hence singlet oxygen generation and photodynamic efficacy 39 . Dimerization is spectrally characterized by a notable deviation from linearity with increasing photosensitizer concentrations. In PEGylated liposomes composed of DPPC (containing two C16 acyl chains), the departure from linearity occurred at a ZnPC:lipid ratio of 0.003 (Fig. 1F) . Corroboratively, ZnPC-ITLs with ZnPC:lipid ratios higher than 0.003 did not produce ROS more extensively or inflicted a greater degree of protein oxidation ( Fig. 2B and E, respectively) than was the case for ITLs with a ZnPC:lipid ratio of 0.003. Contrastingly, in non-PEGylated DMPC liposomes (containing two C14 acyl chains) dimerization was reported to occur at a higher ZnPC:lipid ratio, namely 0.007 27, whereas monomeric ZnPC could be encapsulated at a ZnPC:lipid ratio of 0.013 in non-PEGylated liposomes composed of 1-palmitoyl-2-oleoylphosphatidylcholine and 1,2-dioeloylphosphatidylserine 40, 41 , underscoring the necessity that every liposomal photosensitizer formulation must be individually optimized with respect to the photochemical properties.
On top of the ROS-generating capacity, the optimized ZnPC-ITLs exhibited two features that are considered instrumental to an effective PDT modality. First, ZnPC-ITLs were non-toxic to cancer cells until subjected to PDT, resulting in extensive cell demise that was mainly characterized by a necrotic mode of cell death. It is well-established that necrosis is a potent trigger of the anti-cancer immune response that ensues PDT 28, 42 . The leaked intracellular constituents essentially act as a chemotactic gradient for phagocytic cells of the reticuloendothelial system (RES; monocytes/ macrophages) that home to the damage site to clean up the cellular debris. Moreover, tumor-specific antigens are released from dying and dead cells that are endocytosed by antigen-presenting cells (dendritic cells), which in turn activate naïve T-cells to orchestrate an anti-tumor immune attack 2 . The anti-cancer immune response is further exacerbated by the leakage or exposure of damage-associated molecular patterns (DAMPs) from necrotic cells 43 , which include heat shock protein 70 (HSP70), ATP, high mobility group box-1 (HMGB-1), and calreticulin [44] [45] [46] , that mediate immunogenic apoptosis of cancer cells or act as biochemical cues in the immune response. Taken together, a necrotic mode of cell death is essential to effective cancer removal following PDT. The finding that ZnPC-ITLs mainly induced necrosis therefore constitutes an advantageous predisposition of the ZnPC delivery system. Second, the ZnPC-ITLs were taken up by Sk-Cha1 cells, which was an unexpected finding given that the coating of nanoparticles of any sort with PEG is essentially employed to prevent uptake by cells, particularly of the RES, and surface charge neutralization reduces uptake (Fig. 6 ). Nevertheless, the uptake of ZnPC-ITLs is propitious for several reasons. ROS produced by intracellularly localized ZnPC is considerably more lethal to cancer cells than ROS generated by proximal, extracellularly located ZnPC-ITLs, which were unable to induce membrane perturbations in the in vitro assays (Fig. 3) . Moreover, ZnPC-ITL uptake causes intracellular redistribution of lipophilic components such as ITL-derived phospholipids ( Fig. 6E) and ZnPC [47] [48] [49] to cell-and subcellular membranes 49. The localization of ZnPC in multiple (sub)cellular compartments is expected to expand the number of cell death induction pathways upon PDT. Lastly, the ITLs could be designed to co-encapsulate pharmaceutical agents that either directly exacerbate the phototoxicity of the formulation or interfere with cellular stress response 50 or survival pathways 51, 52 .
The finding that only a fraction of the ZnPC-ITLs was taken up is also advantageous for the envisaged treatment modality. Besides tumor cells, the tumor stroma contains non-malignant cells such as tumor-associated fibroblasts and macrophages that are known to excrete factors such as matrix metalloproteinases, vascular endothelial growth factors, tumor necrosis factor α, and several other types of growth factors and cytokines that stimulate angiogenesis, metastasis, and tumor growth 53, 54 . The ZnPC-ITLs may therefore facilitate the destruction of these cells in addition to the cancer cells, which may result in enhanced PDT efficacy. In support of this, the use of PEGylated liposomes in PDT has been associated with enhanced therapeutic efficacy compared to unPEGylated photosensitizer-containing liposomes or unencapsulated photosensitizers 13, 16, 17, 55, 56 .
Conclusion
A ZnPC-encapsulating liposomal drug delivery system was developed and optimized for PDT of extrahepatic cholangiocarcinomas, a type of cancer that is associated with profound therapeutic recalcitrance in patients. In vitro experiments demonstrated that the ZnPC-ITLs generated substantial amounts of ROS that were capable of oxidizing proteins and lipids. These properties, in combination with the finding that the ZnPC-ITLs were endocytosed by cultured extrahepatic cholangiocarcinoma cells, were responsible for PDT-induced cell death that occurred mainly by necrosis. Subsequent studies with this formulation are underway and entail in vivo proof-of-concept of PDT efficacy, ZnPC pharmacokinetics 57, 58 , and toxicological analysis.
